Low-dose aspirin for primary prevention

This feature requires the newest version of Flash. You can download it here.

A new meta-analysis questions the use of low-dose aspirin for the prevention of cardiovascular events. Given its current wide use, these findings are important and have far-reaching consequences. What are your thoughts?

See:

Meta-analysis questions use of aspirin in primary prevention

Antithrombotic Trialists' (ATT) Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009; 373: 1849-1860.

Algra A and Greving JP. Aspirin in primary prevention: sex and baseline risk matter. Lancet 2009; 373: 1821-1822.

Cite this: Low-dose aspirin for primary prevention - Medscape - Jun 17, 2009.